← All diseases
Lungs and airways
Cystic fibrosis
Do you want to receive a message when there is new research about cystic fibrosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication there is one sentence that explains what was studied — and you receive notification as soon as there is new research on Cystic Fibrosis. View what Premium costs.
Publications and studies (2552)
- Bridging the global survival gap in cystic fibrosis: Evidence from a 30-year longitudinal Mexican cohort. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. CT assessment of body composition and lung evolution in cystic fibrosis after Elexacaftor-Tezacaftor-Ivacaftor: A cohort study. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cystic fibrosis-associated inflammatory bowel disease: a case series and literature review. (2026/08/01) ♡
- Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unique causes of exocrine pancreatic insufficiency: When to consider pancreatic enzyme supplementation: A narrative review. (2026/08/01) ♡
- Diet composition and quality in children with cystic fibrosis in the modulator era: A scoping review. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gastrointestinal and Pancreatic Manifestations of Cystic Fibrosis in the Era of Highly Effective Modulators. (2026/08/01) ♡
- Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. (2026/08/01) ♡
- Bridging the Gap: Translated Medical Education to Support Cystic Fibrosis Centers From Non-English Speaking Countries. (2026/08/01) ♡
- Antiviral defenses are diminished at birth in cystic fibrosis pig airways. (2026/08/01) ♡
- Management Strategies for Hepatotoxicity Associated With Elexacaftor/Tezacaftor/Ivacaftor: Results of a Provider Survey. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gastrointestinal Adverse Events Following Rotavirus Vaccination in Children: A Systematic Review. (2026/08/01) ♡
- Shifting Nutrition Paradigms: Changing Attitudes Towards Diet and Body Perceptions Among People With CF in the Era of Highly Effective Modulators. (2026/08/01) ♡
- MITF Regulates CFTR Expression to Participate in Myocardial Ischemia-Reperfusion Injury. (2026/08/01) ♡
- Developmental dynamics of ovine lung in health and cystic fibrosis at single-cell resolution. (2026/07/31) ♡
- Trafficking Deficiency of TMEM175 Variants in Parkinson's Disease Pathogenesis and the Prospects of Precision Medicine. (2026/07/31) ♡
- Isolation and genomic characterization of bacteriophage Vanta, a lytic Yuavirus infecting clinical strains of Pseudomonas aeruginosa. (2026/07/31) ♡
- Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis. (2026/07/31) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Pathogenic respiratory microbiota in cystic fibrosis: impact of 2 years of triple CFTR modulator therapy. (2026/07/31) ♡
- Assessment of professional practise on Helicobacter pylori in paediatrics: A pan-European study. (2026/07/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Aspergillus fumigatus as a causative agent of a number of dangerous allergic diseases. (2026/07/30) ♡
- Real-world population pharmacokinetic modeling of elexacaftor, tezacaftor, and ivacaftor. (2026/07/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ferroptotic propagation: from single-cell execution to tissue-scale death programs. (2026/07/30) ♡
- A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis. (2026/07/30) ♡
- MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatable traits approach for personalised management of sarcoidosis. (2026/07/29) ♡
- A DNA Tetrahedron-Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis. (2026/07/29) ♡
- A novel stress response pathway mediates biofilm architecture in Pseudomonas aeruginosa. (2026/07/28) ♡
- Subgroup analysis using exchangeability probabilities. (2026/07/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Comment on "Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012 to 2020". (2026/07/28) ♡
- Weight gain is associated with reduced inflammation in children with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor. (2026/07/28) ♡
- Forced vital capacity in pulmonary exacerbations of cystic fibrosis. (2026/07/28) ♡
- Effect of maintenance macrolide de-escalation during the Australian summer on exacerbations of obstructive airway diseases: a randomised, double-blind, placebo-controlled trial. (2026/07/28) ♡
- The role of ETI therapy in managing sinusitis in cystic fibrosis pediatric population: A study on clinical outcomes. (2026/07/28) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. VSL#3(®) supplementation improves fatigue in long COVID: results from the DELong#3 randomized placebo-controlled trial. (2026/07/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. EASE-CF: dietitian-led weight-loss intervention for adults with cystic fibrosis and excess weight: protocol for a feasibility randomised controlled trial. (2026/07/27) ♡
- Efficient AI-supported quantification of network structures in SEM imaged human mucus: A detailed protocol. (2026/07/27) ♡
- A simple diagnostic platform reveals shear stress as critical in biofilm development. (2026/07/25) ♡
- A genotoxin associated with colorectal cancer linked to gut dysbiosis in children with cystic fibrosis. (2026/07/23) ♡
- Disorders of Gut-Brain Interaction like symptoms in Children with Inflammatory Bowel Disease: A Multicenter Prospective Study from the Pediatric IBD Porto Group of the ESPGHAN. (2026/07/22) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Resolution of recurrent pancreatitis and nutritional recovery with CFTR modulator therapy in CFTR-related disorder: a case report. (2026/07/22) ♡
- Beyond Teleconsultation: Exploring the Role of Mobile Health Technologies in Duchenne Muscular Dystrophy. (2026/07/21) ♡
- Trajectories in Oxidative Stress and Corticosteroids Insensitivity in Patient with High Risk of Severe Asthma: Use of FeNO as Biomarker of Respiratory Epithelial Barrier Distress. (2026/07/21) ♡
- Radiomics of the Airway (RadAr): Multi-Scale Airway Phenotyping for Disease Characterization on Routine CT Imaging. (2026/07/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pigtail catheter found in the Lingula of a pediatric patient on VV-ECMO while performing flexible bronchoscopy: a case report on an unexpected finding. (2026/07/21) ♡
- FT-IR Spectroscopy to Discriminate Old from New Pseudomonas aeruginosa Infections in People with Cystic Fibrosis. (2026/07/20) ♡
- Unmasking Early Renal Fibrosis in Polycystic Kidney Disease Using Noninvasive Precision Molecular MRI of Collagen. (2026/07/20) ♡
- CFTR Deficiency Disrupts Bladder Function Through Ion Imbalance and Inflammatory-Apoptotic Signaling. (2026/07/20) ♡
- Real-world experience with a generic formulation of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis. (2026/07/19) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.